Biotech innovation has hit three notable milestones: Bambusa Therapeutics completed enrolment for its first atopic dermatitis drug trial, a one-patient gene-editing therapy corrected a fatal CPS1 ...
Press release - No. 9 / 2026 The Zealand Pharma Board of Directors proposes to elect Camilla Sylvest to the Board of ...
Hospitals filled to capacity. Case counts climbing by the hour. Quarantine became routine. It was the beginning of the ...
PBM reform championed by Sen. Warner is a necessary step to lower health care costs for patients, VA Bio’s John Newby writes ...
Company secures $5M in funding to accelerate its rapid testing platformUSP Validation achieved, reinforcing 20-hour testing methodFaster test results replace the standard 14-day USP sterility test SAN ...
Earlier today, Nautilus Biotechnology released financial results for the quarter ended March 31, 2026. If you haven't received this news release or if you'd like to be added to the company's ...
Outreach initiative supports awareness of agitation and patient engagement as enrollment approaches completion POTOMAC, MD / ACCESS Newswire / April 28, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("I ...
Pitt Street Research and Euroz Hartleys have released research notes on Dimerix highlighting upside potential as progresses ...
As part of this partnership, Mayo Clinic has made an equity investment in Sana Biotech, reflecting a shared goal of creating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results